No abstract available
MeSH terms
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / therapeutic use
-
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Clofazimine / administration & dosage
-
Clofazimine / therapeutic use
-
Cyclosporine / administration & dosage
-
Cyclosporine / therapeutic use
-
Drug Administration Schedule
-
Erythema Nodosum / drug therapy*
-
Erythema Nodosum / immunology
-
Erythema Nodosum / pathology
-
Humans
-
Hypersensitivity, Delayed / drug therapy
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / therapeutic use
-
Leprostatic Agents / administration & dosage
-
Leprostatic Agents / therapeutic use
-
Leprosy / drug therapy*
-
Leprosy / immunology
-
Leprosy / pathology
-
Leprosy, Lepromatous / drug therapy*
-
Leprosy, Lepromatous / immunology
-
Leprosy, Lepromatous / pathology
-
Peripheral Nervous System Diseases / drug therapy*
-
Peripheral Nervous System Diseases / pathology
-
Peripheral Nervous System Diseases / physiopathology
-
Prednisolone / administration & dosage
-
Prednisolone / therapeutic use
-
Prednisone / administration & dosage
-
Prednisone / therapeutic use
-
Thalidomide / administration & dosage
-
Thalidomide / therapeutic use
Substances
-
Anti-Inflammatory Agents
-
Anti-Inflammatory Agents, Non-Steroidal
-
Immunosuppressive Agents
-
Leprostatic Agents
-
Thalidomide
-
Cyclosporine
-
Prednisolone
-
Clofazimine
-
Prednisone